[5/12. Drugs and the dialysis patient].
Koutny
E
E
CHU de Besançon.
Motte
G
G
Woronoff-Lemsi
M C
MC
D000925:Anticoagulants / Q000009:adverse effects / Q000378:metabolism; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000378:metabolism; D002118:Calcium / Q000009:adverse effects / Q000378:metabolism; D064420:Drug-Related Side Effects and Adverse Reactions; D004921:Erythropoietin / Q000009:adverse effects / Q000378:metabolism; D006440:Hemofiltration / Q000009:adverse effects*; D006801:Humans; D008657:Metabolic Clearance Rate; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D006435:Renal Dialysis / Q000009:adverse effects*; D051437:Renal Insufficiency / Q000378:metabolism / Q000628:therapy*
D000925:Anticoagulants; D000959:Antihypertensive Agents; D004921:Erythropoietin; D002118:Calcium